Onconic’s ‘Nesuparib’ Secures FDA Orphan Drug Status Onconic Therapeutics (hereinafter referred to as "Onconic"), a subsidiary of Jeil Pharmaceutical specializing in new drug development, announced… Cheon Okhyeon 2025-03-18